Pharvaris NV Target Price

See Pharvaris NV's analyst price targets ($59) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$38.86

Average Target Price

$58.69

51% upside

13 analysts in the last 4 months

High: $79 | Low: $40

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-10	GuggenheimDebjit Chattopadhyay	$44	13.2% upside
2026-09-09	Wedbush	$50	28.7% upside
2026-09-09	Leerink Partners	$65	67.3% upside
2026-09-09	RBC CapitalNevin Varghese	$62	59.5% upside
2026-09-09	Rosenblatt Securities	$60	54.4% upside
2026-09-09	Morgan Stanley	$62	59.5% upside
2026-09-09	UBS	$79	103.3% upside
2026-09-09	Wells FargoYanan Zhu	$65	67.3% upside
2026-09-08	Oppenheimer	$75	93% upside
2026-08-14	New Street	$60	54.4% upside
2026-08-13	Guggenheim	$40	2.9% upside
2026-07-15	Wells FargoYanan Zhu	$55	41.5% upside
2026-06-25	Morgan StanleyMaxwell Skor	$46	18.4% upside
2026-05-13	UBS	$74	90.4% upside
2026-04-08	Wolfe Research	$42	8.1% upside
2026-03-09	RBC Capital	$52	33.8% upside
2025-12-04	Oppenheimer	$50	28.7% upside
2025-12-04	GuggenheimDebjit Chattopadhyay	$39	0.4% upside
2025-12-04	Morgan StanleyMaxwell Skor	$41	5.5% upside
2025-12-03	Leerink Partners	$38	2.2% downside
2025-10-15	H.C. Wainwright	$60	54.4% upside
2024-10-14	OppenheimerJustin Kim	$42	8.1% upside
2024-04-11	JMP SecuritiesJonathan Wolleben	$50	28.7% upside
2023-09-25	WedbushLaura Chico	$27	30.5% downside
2023-01-11	JMP Securities	$23	40.8% downside
2022-12-09	JMP Securities	$22	43.4% downside

Pharvaris NV (PHVS) FAQ

Pharvaris NV posts a target price of $59. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $59 for PHVS means covering analysts, on average, see the stock 51.0% upside of $38.86 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for PHVS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Pharvaris NV's other metric pages and overview cover the third.

Judging Pharvaris NV against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $59 here, then scan peer and history charts to see if the gap is persistent.